Clinical Trials in Maryland

Showing 6601-6620 of 17,687 trials

School-Based Depression Prevention for Adolescents With ADHD

NCT04104841

The purpose of this study is to develop a modified behavioral activation program in adolescents with ADHD to be implemented by school mental health providers in an urban, low-income school district. Subsequently the investigators will examine its effectiveness in reducing depressive symptoms and improving emotion regulation and reward responsivity, compared to usual care.

Attention Deficit Hyperactivity DisorderDepressive Symptoms

University of Maryland, College Park50 participantsStarted Aug 2018

College Park, Maryland, United States

COMPLETEDPhase 315 miles

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

NCT04206605

The main aim of this study is to check if repeated subcutaneous (SC) injections of lanadelumab can prevent angioedema attacks in teenagers and adults with non-histaminergic angioedema with normal C1-INH. Another aim is to check if they tolerate the repeated SC injections. Participants will receive a SC injection of lanadelumab every two weeks for 26 weeks. The first two doses of lanadelumab will be given at the study clinic. Once a participant (and/or parent/caregiver) has been appropriately trained, lanadelumab can be self-injected. Visits to the study clinic are planned for the first, third and fourth week and then every 4 weeks.

Angioedema

Takeda77 participantsStarted May 2020

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • San Diego, California, United States +42 more locations

School-Based Depression Prevention for Adolescents With ADHD

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

Find Trials by Condition in Maryland

A Study of TAK-994 in Adults With Narcolepsy

Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function